Fasciola hepatica
Year Started: 2023
- Access:
- Open only through collaboration
- Type:
- Cross-sectional
- Status:
- In progress
- Consent restrictions:
- Human genetic analysis restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| Clinical records | Immediate |
| Followup records | > 6 months |
| Freezer temperature logs | > 6 months |
| Survey data | Immediate |
| Treatment records | 0 - 3 months |
| Participant Ethnicity | Immediate |
Both sexes
Child (6 - 12 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Microscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Stool | -85°C to -60°C | Affected | 0 - 10% | ||
| Urine (random) | -85°C to -60°C | Affected | 0 - 10% | ||
| Serum | -85°C to -60°C | Affected | 0 - 10% | ||
| Isolated peripheral blood mononuclear cells (non viable) | -85°C to -60°C | Affected | 0 - 10% | ||
| Other | -85°C to -60°C | Affected | 0 - 10% |
Fasciola hepatica
Fasciola hepatica (Copy 1)
Year Started: 2023
- Access:
- Open only through collaboration
- Type:
- Cross-sectional
- Status:
- In progress
- Consent restrictions:
- Human genetic analysis restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| Clinical records | Immediate |
| Followup records | > 6 months |
| Freezer temperature logs | > 6 months |
| Survey data | Immediate |
| Treatment records | 0 - 3 months |
| Participant Ethnicity | Immediate |
Both sexes
Child (6 - 12 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Microscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Isolated peripheral blood mononuclear cells (non viable) | -85°C to -60°C | Affected | 0 - 10% | ||
| Serum | -85°C to -60°C | Affected | 0 - 10% | ||
| Other | -85°C to -60°C | Affected | 0 - 10% | ||
| Urine (random) | -85°C to -60°C | Affected | 0 - 10% | ||
| Stool | -85°C to -60°C | Affected | 0 - 10% |